Your session is about to expire
← Back to Search
Other
Xylitol Wipes for Bloodstream Infections in Stem Cell Transplant Patients
Phase 2
Recruiting
Led By Christopher Dandoy, MD, MSc
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 33 days
Summary
This trial will evaluate if twice daily wipes with xylitol can reduce bloodstream infections in kids getting stem cell transplants, helping to prevent morbidity and mortality.
Who is the study for?
This trial is for children and young adults aged 4 months to 25 years who are undergoing stem cell transplantation. Participants must have at least one tooth, not use xylitol-containing products during the study, and be treated at specific hospitals. Those with allergies to grapes or xylitol, recent radiation treatment in the head or neck area, or those having a transplant without prior chemotherapy/radiation are excluded.
What is being tested?
The trial tests if using xylitol wipes in the mouth twice daily can prevent bloodstream infections from oral bacteria in pediatric patients receiving stem cell transplants. It's a randomized study where some will get xylitol wipes and others a placebo, without knowing which they received.
What are the potential side effects?
Xylitol is generally well-tolerated but may cause allergic reactions in rare cases. Since it's used orally as a wipe here, potential side effects might include local irritation or discomfort around the mouth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 33 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~33 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Bacteremia from an oral organism
Secondary study objectives
Bacteremia
Dental Plaque
Gingivitis
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: XylitolExperimental Treatment1 Intervention
Xylitol, a naturally occurring sugar alcohol found in plums, strawberries, and various vegetables such as cauliflower, has been approved for use in food by the US FDA since 1963. Spiffies Xylitol Wipes will be used.
Group II: Grape-flavored WipesPlacebo Group1 Intervention
Grape-flavored wipes will be used with 2 drops of PCCA colorless grape flavoring. The grape-flavored wipes each contain a solution of 0.9% Sodium Chloride, purified water, and Benzalkonium chloride. PCCA artificial colorless grape flavoring will be used. The PCCA grape flavoring contains propylene glycol, ethyl alcohol, and artificial flavoring.
Find a Location
Who is running the clinical trial?
National Institute of Dental and Craniofacial Research (NIDCR)NIH
306 Previous Clinical Trials
849,651 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiLead Sponsor
837 Previous Clinical Trials
6,564,918 Total Patients Enrolled
Christopher Dandoy, MD, MScPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had radiation for cancer in my mouth, head, or neck within the last 6 months.I am scheduled for a stem cell transplant at a specified hospital.I agree not to use xylitol-containing gum or toothpaste during the study.I am receiving extra radiation to my head as part of my total body treatment.I am having a stem cell transplant without prior chemotherapy or radiation.I am willing and able to follow all study rules and attend all appointments.I am between 4 months and 25 years old.I have at least one tooth.
Research Study Groups:
This trial has the following groups:- Group 1: Grape-flavored Wipes
- Group 2: Xylitol
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger